Biogen Inc. (BIIB) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Biogen BIIB and Japan-based partner, Eisai, announced an update regarding the regulatory review of an application seeking the ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does ...

Brandon Lake Last week Weeks at no. 1 Weeks on chart B.M.Lake, B.W.Hastings, M.Nichols, Z.J.Lawson, S.Furtick M.Nichols Brandon Lake/Essential/PLG Week of January 25, 2025 click to see more ...

Biogen Inc. announced that the FDA has accepted and the EMA has validated its supplemental New Drug Application for a higher dose regimen of nusinersen, intended for treating spinal muscular ...

The Cambridge drugmaker said the smaller research organization "will match the needs of a prioritized preclinical portfolio." Biogen Inc. is making cuts to its research organization as the ...

Leadership transparency will be key to organizational success in 2025. Many organizations still struggle to build trust with their employees, especially during confusing return-to-office policies.